PubRank

James R Jett

Author PubWeight™ 127.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005 9.83
2 Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012 8.71
3 Computed tomography screening and lung cancer outcomes. JAMA 2007 8.01
4 Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002 5.10
5 Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003 4.72
6 The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012 4.68
7 CT screening for lung cancer: five-year prospective experience. Radiology 2005 4.33
8 Non-small-cell lung cancer. Lancet 2011 3.45
9 Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007 3.44
10 Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 2010 3.13
11 Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations. J Thorac Oncol 2012 3.10
12 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest 2009 2.45
13 The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003 2.32
14 Advances in chemotherapy of non-small cell lung cancer. Chest 2006 2.00
15 Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004 1.81
16 Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004 1.77
17 Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006 1.75
18 Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg 2004 1.67
19 Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials. Cancer 2010 1.63
20 A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 2006 1.59
21 Change in smoking status after spiral chest computed tomography scan screening. Cancer 2003 1.55
22 Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002 1.55
23 Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 2005 1.51
24 Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007 1.43
25 Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer 2007 1.36
26 Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005 1.27
27 A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 2006 1.26
28 Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer 2004 1.19
29 Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients. Chest 2007 1.19
30 The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest 2007 1.16
31 Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer 2009 1.15
32 A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer 2007 1.14
33 Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 2005 1.13
34 Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study. J Thorac Oncol 2012 1.12
35 Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012 1.11
36 Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005 1.11
37 Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer. J Clin Oncol 2005 1.07
38 Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancer. Clin Cancer Res 2007 1.05
39 Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev 2012 1.04
40 Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res 2005 1.03
41 The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer 2007 0.96
42 Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc 2008 0.94
43 Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference. Chest 2005 0.94
44 Imatinib mesylate-induced interstitial pneumonitis. Mayo Clin Proc 2003 0.94
45 Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. J Thorac Oncol 2008 0.92
46 Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer 2005 0.92
47 An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management. Am J Respir Crit Care Med 2015 0.90
48 Computed tomographic screening for lung cancer: home run or foul ball? Mayo Clin Proc 2003 0.90
49 Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer. Cancer Biol Ther 2010 0.89
50 Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clin Proc 2004 0.88
51 Change in smoking status after low-dose spiral chest CT screening for lung cancer: opportunity for smoking intervention. Thorax 2009 0.88
52 Small cell lung cancer: current therapy and promising new regimens. Oncologist 2002 0.87
53 Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population. AJR Am J Roentgenol 2005 0.86
54 Glomus tumor of the trachea: value of multidetector computed tomographic virtual bronchoscopy. Mayo Clin Proc 2004 0.86
55 Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study. J Thorac Oncol 2009 0.85
56 Update on screening for lung cancer. Semin Respir Crit Care Med 2008 0.85
57 Screening for lung cancer: the US studies. J Surg Oncol 2013 0.84
58 Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007 0.83
59 Pathologic review of the Mayo Lung Project cancers [corrected]. Is there a case for misdiagnosis or overdiagnosis of lung carcinoma in the screened group? Cancer 2002 0.83
60 Phase II NCCTG trial of oral topotecan and paclitaxel with G-CSF (filgrastim) support in patients with previously untreated extensive-stage small cell lung cancer. Am J Clin Oncol 2006 0.83
61 Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer 2003 0.83
62 Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens. Am J Respir Crit Care Med 2009 0.82
63 Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology 2008 0.81
64 Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423. Cancer 2010 0.81
65 Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study. Am J Clin Oncol 2003 0.79
66 Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clin Cancer Res 2005 0.79
67 Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis. Curr Opin Pulm Med 2010 0.79
68 Screening for non-small cell lung cancer. Semin Oncol 2005 0.78
69 Systemic treatment of advanced lung carcinoid tumors: show me the data! Chest 2013 0.77
70 Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group. J Thorac Oncol 2006 0.77
71 Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer 2009 0.77
72 Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group Study. Am J Clin Oncol 2010 0.77
73 Road ahead to respiratory health: experts chart future research directions. Respirology 2009 0.76
74 Lung cancer screening results: easily misunderstood. Mayo Clin Proc 2007 0.76
75 A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1). Int J Radiat Oncol Biol Phys 2002 0.76
76 A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer 2004 0.75
77 Screening for lung cancer: no longer a taboo subject. J Clin Oncol 2002 0.75
78 State of the Journal. J Thorac Oncol 2009 0.75
79 Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials. J Thorac Oncol 2006 0.75
80 Expert opinion: role of percutaneous biopsy of part-solid nodules in the IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma. J Thorac Imaging 2011 0.75
81 Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution. Lung Cancer 2005 0.75
82 Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation. Hum Pathol 2013 0.75
83 State of the journal: 2011. J Thorac Oncol 2011 0.75
84 Advances in treatment for non-small cell lung cancer. Int J Tuberc Lung Dis 2010 0.75